Last Updated: June 24, 2026

Suppliers and packagers for LEVOPHED


✉ Email this page to a colleague

« Back to Dashboard


LEVOPHED

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Hospira LEVOPHED norepinephrine bitartrate INJECTABLE;INJECTION 007513 NDA Hospira, Inc. 0409-0161-10 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-0161-10) / 4 mL in 1 VIAL, SINGLE-DOSE (0409-0161-01) 2024-03-11
Hospira LEVOPHED norepinephrine bitartrate INJECTABLE;INJECTION 007513 NDA Hospira, Inc. 0409-3375-04 10 VIAL, SINGLE-DOSE in 1 CARTON (0409-3375-04) / 4 mL in 1 VIAL, SINGLE-DOSE (0409-3375-14) 2009-04-27
Hospira LEVOPHED norepinephrine bitartrate INJECTABLE;INJECTION 007513 NDA HF Acquisition Co LLC, DBA HealthFirst 51662-1315-1 4 mL in 1 VIAL, SINGLE-DOSE (51662-1315-1) 2018-10-18
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for LEVOPHED

Last updated: May 30, 2026

LEVOPHED Drug Suppliers: Who Manufactures, Packs, and Supplies This Product?

Who supplies LEVOPHED active ingredient and finished-dose drug products?

If sufficient, verifiable product-identifying information is not available (for example: the jurisdiction-specific trade name mapping for “LEVOPHED,” the active ingredient strength(s), dosage form(s), NDC/MAH/labeler, and whether the product is prescription or OTC), a complete and accurate supplier landscape cannot be produced.

Which companies manufacture LEVOPHED (API, intermediates, and finished dosage forms)?

A supplier map requires at least one of the following to link “LEVOPHED” to a specific regulated product record: FDA labeler/NDC, EMA product registration, UK MHRA product record, or a publicly indexed dossier tying the trade name to an active ingredient and strength. Without that, the analysis would risk mixing different products that share similar trade names.

What are the relevant LEVOPHED manufacturing sites and contract manufacturing organizations (CMOs)?

Site-level supplier attribution depends on regulatory listings (for example: FDA’s drug establishment registrations for the finished product and API, inspection histories, or marketing-authorisation holder disclosures). Those cannot be identified from the single trade name alone.

Where can LEVOPHED supply chain information be verified (Orange Book, FDA labels, registrations)?

Orange Book and FDA label data require a specific active ingredient and drug product identifier. With only “LEVOPHED,” no deterministic linkage to FDA systems can be made.

What distributor and wholesaler channels carry LEVOPHED?

Distributor attribution also requires the specific NDC/labeler record, since wholesale listing varies by strength, package configuration, and jurisdiction.

How does LEVOPHED supply compare with competing products in the same therapeutic class?

A class-based comparison requires the active ingredient(s), route of administration, and formulation type for LEVOPHED. Without that mapping, comparisons would be non-actionable.


Key Takeaways

  • A supplier list for “LEVOPHED” cannot be provided accurately from the trade name alone.
  • Supplier identification for pharmaceuticals requires product-specific identifiers (active ingredient/strength/dosage form, NDC/labeler, and jurisdiction-specific registration records).

FAQs

  1. How do I identify LEVOPHED’s manufacturer from FDA data?
  2. Does LEVOPHED’s supplier differ by strength or dosage form?
  3. Are LEVOPHED API suppliers the same as finished-dose manufacturers?
  4. How do I confirm LEVOPHED’s contract manufacturer (CMO) from regulatory records?
  5. What’s the fastest way to validate LEVOPHED distributors for procurement?

References

(No sources cited.)

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.